The evolving landscape of MS John Woolmore Consultant Neurologist UHB FIN14-C173. Date of preparation: September 2014.
New Antiepileptic Medications Drug Profiles, Efficacy, Safety, and Tolerability.
A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial Seung-Jung Park, MD, PhD, University.
Profile Analysis of Cascade Impactor Data: An Alternative View Andrew R Clark, Ph.D. Orally Inhaled and Nasal Drug Products Subcommittee of the Advisory.
Newer and Future (Device) Therapies for Heart Failure William T. Abraham, MD, FACP, FACC, FAHA, FESC Professor of Medicine, Physiology, and Cell Biology.
Dr A. De Simone La terapia di resincronizzazione ed il trapianto in pazienti oncologici.
Use of Foreign Data for Approval
Optimizing Treatment for Her 2 Positive Early Stage Breast Cancer Patients
1 A frank dialogue on the future of HIV treatment All the way from the factory to the patient Sunday 20 th July 2014, 13:30 – 15:30 Presented at the 20.
Phase I studies in non-oncology: Dosing & Designs April 18 th 2012 Sharon O’Byrne Senior Medical Director Genentech Research & Early Development.
Agenda 3:00 PMIntroduction to Workshop Barry Reisberg, M.D. 3:05 PM Cognitive dynamics: how variability in brain Kenneth Rockwood M.D., FRCPC, FRCP function.
Objectives
